Amplifon, IT0004056880

Equita upgrades Amplifon stock from Hold to Buy

Published on 10/01/2026 at 11:16 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue reached EUR 606.00 million in the second quarter of 2026, up 2.20 percent. Amplifon stock costs EUR 12.01 on October 1, 2026 after EUR 12.07.

Modernes Hörzentrum mit Beratungsraum und Hörgeräte-Ausstellung, fotorealistisch
Fotorealistisches Bild zeigt modernen Hörzentrum-Ladenraum, passend zu Amplifon S.p.A. mit ISIN IT0004056880, Sektor Medizintechnik, Illustration mit AI erstellt.

Amplifon (ISIN IT0004056880) was trading at EUR 12.01 at Lang & Schwarz on October 1, 2026 at 11:06 a.m. CEST, down 0.50 percent versus the prior close of EUR 12.07. According to Fintel on September 24, 2026, EQUITA SIM upgraded Amplifon's rating from Hold to Buy on September 18, 2026.

Equita turns more positive

The rating change gives Amplifon a fresh analyst signal as the company prepares for the next earnings update. Fintel also reported that the consensus target was EUR 13.59 on September 14, 2026, compared with EUR 13.60 on August 28, 2026, a 0.07 percent decrease.

The recommendation shift is notable because it came after Amplifon's second-quarter operating update. Investing.com reported on July 30, 2026, that second-quarter revenue rose 2.20 percent to EUR 606.00 million, while adjusted EBITDA margin expanded 90 basis points to 25.80 percent.

Growth meets integration risk

Investing.com also said organic growth reached 4.70 percent in the second quarter of 2026, the strongest rate in two years, while management maintained 2026 guidance for organic growth above 3.00 percent and an adjusted EBITDA margin improvement of about 1.00 percentage point. The source said the GN Hearing acquisition remained on track for completion by the end of 2026.

Il Sole 24 ORE reported on September 23, 2026, that the deal could generate net synergies of EUR 60.00-80.00 million, mainly by raising GN Hearing internal sourcing from 40.00 percent to 90.00 percent by 2029. That opportunity is balanced by integration execution and financing demands as Amplifon combines organic growth with a large transaction.

Stock remains below yearly high

Amplifon stock stood 24.18 percent below its 52-week high of EUR 15.84 on October 1, 2026, based on the EUR 12.01 Lang & Schwarz price. The 52-week low was EUR 7.84, placing the share 53.19 percent above that level.

Investing.com lists October 29, 2026, as Amplifon's next earnings date and an average 12-month analyst target of EUR 13.63 across 16 analysts. The target is 13.47 percent above the Lang & Schwarz price, although that comparison uses a consensus level rather than a single analyst forecast.

Price and key stock data

Amplifon was trading at EUR 12.01 at Lang & Schwarz on October 1, 2026 at 11:06 a.m. CEST, down 0.50 percent versus the EUR 12.07 prior close dated September 30, 2026. The further course of trading is shown by the continuously updated real-time quote of Amplifon stock.

Amplifon stock facts

  • Company: Amplifon S.p.A.
  • ISIN: IT0004056880
  • WKN: A0JMJX
  • Ticker: AMPF
  • Primary exchange: Milan Stock Exchange
  • Price Lang & Schwarz (as of October 1, 2026, 11:06 a.m. CEST): EUR 12.01
  • Change versus prior close: minus 0.50 percent
  • Prior close Lang & Schwarz (September 30, 2026): EUR 12.07
  • Market capitalization: EUR 2.6 billion (as of October 1, 2026)
  • 52-week range: EUR 7.84-EUR 15.84 (as of October 1, 2026)
  • Sector / Industry: Healthcare / Medical - Distribution
  • Index membership: FTSE MIB
  • Next earnings date: October 29, 2026

More news and analyses on Amplifon stock

Disclaimer...

en | IT0004056880 | AMPLIFON | boerse | 70209403 | bgmi